among adults in the United States. [1] It is characterized by repeated episodes of partial or complete upper airway obstruction during sleep and is accompanied by intermi ent hypoxemia, increased respiratory eff ort, and sleep disturbance. Obesity, age, and male gender are the most important risk factors for this syndrome. The main manifestations of this condition are respiratory pauses during sleep, followed by loud snorts and also excessive daytime sleepiness (EDS). [2] Patients may complain from a sensation of choking, diffi culty in falling asleep at night, [3] [4] [5] morning headaches, [3, 6, 7] and nightmares. [8] OSAS may cause serious consequences including arterial and pulmonary hypertension, [9] cardiovascular diseases, [10] motor vehicle accidents, [11] impaired cognition, and psychiatric symptoms including depression, irritability, and anxiety. [12, 13] While each of these conditions may signifi cantly impair the quality of life, [14] many of the patients remain unrecognized with huge medical and
INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is a common sleep-related breathing disorder with a prevalence of 2-4% economic burden on both themselves and the society. [3, 15] The delay in diagnosis of OSAS has been partially a ributed to the nature of this syndrome, as snoring and nocturnal respiratory pauses may not a ract appropriate a ention of suff erers. Hence, a be er understanding of this condition, its complications, and the presenting symptoms is of great value.
According to International Classifi cation of Sleep Disorders (ICSD-II) published by the American Academy of Sleep Medicine (AASM), OSAS is diagnosed with either a respiratory disturbance index (RDI) ≥15 irrespective of the presence of symptoms, or an RDI >5 accompanied by any of the following features: 1) sleep a acks, EDS, fatigue, or insomnia; 2) awakening with a chocking feeling; 3) loud snoring and/or breathing pauses reported by bed partner. RDI is ascertained by mean number of apneas + hypopneas + respiratory eff ort-related arousals per hour of sleep. [16] The standard laboratory technique for the diagnosis of sleep apnea is overnight polysomnography.
[17] The treatment of choice for OSAS is continuous positive airway pressure (CPAP); however, the adherence to this device may be aff ected by psychiatric status, especially claustrophobia. [18] Among the adverse consequences, an association between mood disturbances and anxiety disorder with OSAS has been shown in a large body of epidemiological studies. [19] [20] [21] [22] Nonetheless, there are studies that show contrary results to such a correlation. [15, 23] Moreover, overlapping symptoms like passivity and lack of initiation, loss of facial expression, and slowed psychomotor function, which may be noticed in both OSAS (as a result of diurnal drowsiness) and depression, may make it diffi cult to distinguish between these conditions. [13, 23] Hence, further investigations in this area, particularly largescale studies, are necessary to understand this relationship and the nature of these conditions. The purpose of this study is to determine the prevalence of depression and anxiety in patients diagnosed with OSAS. Also, this study investigated the association of depression and anxiety with body mass index (BMI), Epworth sleepiness scale (ESS), and the severity of OSAS in these patients.
MATERIALS AND METHODS
We conducted this cross-sectional study at the sleep laboratory of Ibn-e-Sina Hospital, Mashhad, Iran, from September 2008 to May 2012. We did polysomnography on the patients referred to this center during this period of time and 191 patients were diagnosed with OSAS. Incomplete and unreliable cases were removed from the study; hence, the data were gathered from 178 patients who were diagnosed with OSAS according to ICSD-II. [16] Prior to data collection, informed consent was obtained from each participant. The information regarding age, gender, weight, height, and medical history of the patients was gathered and analyzed, and unnecessary data were omitted. Detailed history of the presenting symptoms including snoring, daytime sleepiness, nocturnal chocking, nightmares, and headaches was taken by a neurologist. We also asked the patients to determine their chief complaint that made them seek for medical help. To assess the psychiatric status, the participants were asked to fi ll the Beck depression inventory (BDI-II) and the Beck anxiety inventory (BAI). The BDI-II (revised in 1996) is a self-report questionnaire consisting of 21 multiple-choice questions regarding depression symptoms. [24] BAI is also a self-report questionnaire consisting of 21 multiple-choice questions to evaluate the severity of anxiety symptoms. BDI, BAI, and their applicability have been validated in Iranian population. [25] According to Mental Health Research Centre, Tehran Psychiatric Institute, the Beck scores categorized the severity of anxiety and depression into four groups in following manner. BDI categories are normal (0-9), mild (10-15), moderate (16) (17) (18) (19) (20) (21) (22) (23) , and severe . Regarding the BAI, the categories are normal (0-7), mild (8) (9) (10) (11) (12) (13) (14) (15) , moderate (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) , and severe (26-63).
[26] Daytime sleepiness was assessed by employing the ESS, which constitutes eight questions regarding dozing in diff erent passive situations. According to ESS, the chance of falling asleep in each situation is scored from 0 to 3. The sum of the responses provides a global ranking ranging from 0 to 24. The severity of daytime sleepiness is categorized into four groups: normal (0-8), mild (9-12), moderate (13) (14) (15) (16) , and severe (>16).
[27] Insomnia was considered as diffi culty to fall asleep or maintaining the sleep persistency. [28] To evaluate obesity, we determined the BMI, which is calculated as body weight in kilograms divided by the square of the height in meters. [29] Then the participants underwent overnight polysomnography. Based on the Manual of AASM criteria, sleep apneas were ascertained as ≥10 seconds of air fl ow pauses. [16] A 50% decrement in the amplitude of baseline airfl ow followed by ≥3% of oxygen desaturation/or electroencephalography (EEG) recorded arousal was considered as hypopnea. [16] The severity of OSAS was determined by apnea-hypopnea index (AHI; mean number of apnea + hypopnea per hour of sleep). In this study, AHI was classifi ed as mild (5-15), moderate (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , and severe (>30). [16] 
Statistical analysis
The collected data were analyzed employing SPSS so ware (version 16). The correlations between variables were investigated using χ 2 test, replaced by Fisher's exact test in the case of expected cell ≤5. The signifi cance level was set at P ≤ 0.05.
RESULTS
According to this study, snoring was the most frequent symptom in patients suffering from OSAS (66.3%), followed by anxiety (53.9%) and then chocking (47.2%) and depression (46.1%) [ Table 1 ]. This study also showed that among the chief complaints, insomnia was the most frequent symptom (20.2%) followed by anxiety and chocking (each one constituting 13.5%) [ Figure 1 ]. Another fi nding of this study was the association between anxiety and chocking. This study showed that the incidence of chocking in patients suff ering from anxiety was almost two times more than those without anxiety symptoms [odds ratio (OR): 2.03, confi dence interval (CI): 1.11-3.7, P: 0.020].
Our study also compared the incidences of main OSAS symptoms in males and females [ Table 1 ]. It showed that the incidence of anxiety was not associated with gender, which might be due to the abnormal distribution of males and females in the target population (males: 85.52%, females: 13.48%). In other words, we could not provide evidence showing a correlation between gender and any of the main symptoms of OSAS in these patients.
We also investigated the association of BMI and ESS with the frequency of OSAS main symptoms. The mean BMI and ESS were higher in OSAS patients with anxiety, depression, insomnia, snoring, nightmare, sleepiness, headache, and chocking [ Table 2 ].
The association between the OSAS severity and its symptoms was also investigated. In terms of severity, OSAS was categorized into mild, moderate, and severe groups This study showed that anxiety (P: 0.001) and chocking (P < 0.001) were signifi cantly more frequent among patients with severe OSAS; on the other hand, sleepiness was observed more in mild OSAS (P: 0.001). We did not fi nd any evidence indicating an association between the severity of OSAS and incidence of depression, insomnia, snoring, headache, and nightmare [ Table 3 ].
DISCUSSION
This is the fi rst cross-sectional study in the Middle East area that examined the presenting features of OSAS BMI=Body mass index; ESS=Epworth sleepiness scale; OSAS=Obstructive sleep apnea syndrome; This study showed that BMI and ESS were higher in patients with anxiety, depression, insomnia, snoring, nightmare, sleepiness, headache, and chocking. According to χ 2 test, BMI was signifi cantly higher in OSAS patients suffering from anxiety (P: 0.023). At the same time, ESS was signifi cantly higher in patients complaining from depression (P: 0.005), insomnia (P: 0.011), and chocking (P: 0.029) OSAS=Obstructive sleep apnea syndrome; AHI=Apnea-hypopnea index; OSAS=Obstructive sleep apnea syndrome; According to χ 2 test, the frequency of anxiety and chocking was signifi cantly higher in patients suffering from severe OSAS (P: 0.001 in anxiety and <0.001 in chocking). On the contrary, sleepiness had a reverse correlation with the severity of OSAS (P: 0.001)
Figure 1:
The incidences of the common chief complaints in patients with OSAS in terms of chief complaints and other presenting complaints. According to this study, snoring was the most frequent symptom in our patients (66.3%), which is compatible with most of the previous studies. [9, 15, 22] However, it constituted only 4.5% of the chief complaints among our patients. At the same time, insomnia was the most prevalent chief complaint, while it was at the fi h position among the symptoms of OSAS. Hence, it can be concluded that insomnia, compared with snoring, more effi ciently forces OSAS patients in Iran to ask for medical help. Anxiety was at the second position among both OSAS symptoms and chief complaints, followed by chocking. While the prevalence of depression, as a feature of OSAS, was almost similar to that of chocking, depression had a greater share as a chief complaint. Our study also showed that in spite of low prevalence of headaches and nightmares as symptoms of OSAS, they had a signifi cant share as the chief complaints of OSAS patients. This study also showed that sleepiness was not a frequent symptom (14.6%), which is in contrast to most descriptive studies. [9, 13, 20, 30] These fi ndings show that snoring and sleepiness (two of the main features of OSAS [12] ) were not the signifi cant complaints making the patients ask for medical a ention. This fact may be a ributed to several factors, in particular, the lack of public information regarding the importance of sleep apnea and its presenting picture in the studied population. As a result, it can be predicted that most OSA patients in Iran mainly complain of symptoms other than snoring and sleepiness such as insomnia, anxiety, depression, and headaches.
In addition, our study showed higher frequency of anxiety and depressive symptoms among OSAS patients compared to the general Iranian population, which was calculated in previous studies applying BDI-II and BAI. [31, 32] Regarding the relationship between sex and OSAS symptoms, anxiety was estimated in 53.89% of male and 54.2% of female OSAS patients in our study. As the distribution of sex ratio was not equal (86.5% men vs. 13.5% women), we calculated the OR for sex (male/ female), which was 1.011 for OSAS patients with anxiety (P: 0.02). Accordingly, we showed the same incidence of anxiety in male and female patients who suff ered from sleep apnea. This fi nding is in contrast to the results of previous epidemiologic studies in which the prevalence of atypical symptoms like anxiety and depression was reported to be more among female patients. [33] [34] [35] This diff erence may arise from factors such as methodology and race-related difference in OSAS symptoms. [2, 12] Regarding the incidence of depression in our study, 48% of male and 33% of female OSAS patients had depressive symptoms. The OR of depressive female/male in OSAS patients was 0.54 with CI of 0.22-1.34; however, from the statistics point of view, the evidence was not signifi cant (P: 0.178). In other words, although we showed higher frequency of depressive symptoms in OSAS, which is compatible with large studies, [33, 35] we failed to demonstrate any association between sex and depression in OSAS suff erers. Furthermore, we investigated the relationship between the severity of sleep apnea (determined by AHI levels) and OSAS symptoms. We found evidence that the prevalence of anxiety increased as the severity of OSAS was intensifi ed (P: 0.01). This fi nding is consistent with some other epidemiologic studies. [19, 20, 36] On the other hand, while a correlation between the severity of sleep apnea and depression, snoring, headaches, insomnia, and nightmare has been demonstrated in some previous studies, [20, 21] we failed to show such a correlation. Again, race diff erences or methodology may be considered in this area.
Finally, we studied the association of BMI and ESS with the severity of sleep apnea and the presenting symptoms. Similar to multiple previous studies, [2, 15, 21, 37, 38] our study demonstrated that high levels of AHI (indicating the severity of OSAS) correlated with high BMI. In other words, severe OSAS is more frequent in people with high BMI. Moreover, we examined the relationship of ESS and BMI with the symptoms of OSAS. In terms of ESS, this study showed that ESS was around 1.52 (CI: 0.13-3.18) higher in OSAS individuals with depression symptoms; however, the evidence was very weak (P: 0.071) and this correlation may be a ributed to overlapping symptoms like fatigue and tendency to dozing. On the other hand, we did not fi nd an association between ESS and anxiety. In terms of BMI, we did not fi nd any signifi cant link between BMI and depression symptoms but found evidence showing that the mean BMI in OSAS patients with anxiety was 1.76 (CI: 0.24-3.28) higher than in OSAS patients without this symptom (P: 0.023). In summary, our study indicated that high BMI not only was associated with the severity of OSAS but also increased the frequency of anxiety.
Although we achieved interesting results, there were limitations in our study. We did not determine anxiety disorders and depression as a disorder. Symptoms regarding anxiety and depression, which were evaluated by BAI and BDI-II, could be assessed in other means. As a result, diff erent data may be achieved according to methodology. The size of studied population may also be a limitation. In addition, cultural confl icts may infl uence the results. For example, data regarding sexual function (particularly among women in a traditional society), job performance, and impulsivity may be false. Considering these facts, further investigation is still a necessity in this area.
CONCLUSION
We conclude that the likelihood of presenting anxiety was higher in OSAS patients than in the general population. We also showed that anxiety was more frequent in OSAS patients with high BMI and severe OSAS. In addition, this study, which was conducted in a Middle East region, demonstrated the high possibility of presenting OSAS with atypical features such as anxiety, headaches, and insomnia. Therefore, it is advisable for a variety of medical specialists including psychiatrists to keep in mind the probable diagnosis of OSAS in such conditions, particularly in societies with low public information regarding this serious syndrome.
